Ratings Balaji Amines Limited

Equities

BALAMINES

INE050E01027

Market Closed - Bombay S.E. Other stock markets 06:00:52 2024-06-10 am EDT			5-day change	1st Jan Change
2,183 ^INR	+1.44%		+4.40%	-18.19%

May. 10	Transcript : Balaji Amines Limited, Q4 2024 Earnings Call, May 10, 2024
May. 08	Balaji Amines' Consolidated Profit Jumps in Fiscal Q4; Shares Surge 10%	MT

Summary

Overall, the company has poor fundamentals for a medium to long-term investment strategy.
The company's Refinitiv ESG score, based on a relative ranking of the company within its sector, comes out particularly poor.

Strengths

The company returns high margins, thereby supporting business profitability.
Analysts covering this company mostly recommend stock overweighting or purchase.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.

Weaknesses

As estimated by analysts, this group is among those businesses with the lowest growth prospects.
The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
With an expected P/E ratio at 34.94 and 22.88 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
Over the past four months, analysts' average price target has been revised downwards significantly.
The average consensus view of analysts covering the stock has deteriorated over the past four months.
Over the past twelve months, analysts' opinions have been revised negatively.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Specialty Chemicals

	1st Jan change	Capi.	ESG Refinitiv
BALAJI AMINES LIMITED	-18.19%	835M	D+
ECOLAB INC.	+19.62%	68.31B	A-
SIKA AG	-1.28%	48.49B	A-
GIVAUDAN SA	+25.20%	44.42B	B+
FUJIFILM HOLDINGS CORPORATION	+32.00%	28.29B	A-
EMS-CHEMIE HOLDING AG	+7.34%	19.12B	C+
SYMRISE AG	+10.50%	16.64B	B+
CELANESE CORPORATION	-6.97%	16B	B+
POSCO FUTURE M CO., LTD.	-23.40%	15.84B	A-
ALBEMARLE CORPORATION	-20.95%	13.51B	C+

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes